-
Study aim
-
Determination and comparison of the effects of oral medroxyprogesterone and oral donepezil on improving respiratory status and facilitating mechanical ventilation discontinuation in patients undergoing mechanical ventilation in intensive care units
-
Design
-
Patients will be randomly divided into 3 groups receiving 10 mg daily Denepezil or MP or placebo randomly divided by permissive block method and will use their own medicine once a day for 10 days. Therefore, demographic and clinical data of registered patients, as well as medication history, clinical profiles, GCS and Sophia Score are reported.
-
Settings and conduct
-
Intensive care units of Dr. Rahnemoon Hospital of Yazd
-
Participants/Inclusion and exclusion criteria
-
Mechanical ventilation through endotracheal tube for at least 24 hours, oxygen saturation greater than 90%, FIO2 less than 50% and PEEP less than 8 cm water, hemodynamic stability over the past 12 hours, sedation withdrawal or sedation reduction Over the past 48 hours, neurological status stability with Ramsay's score was less than 5 and body temperature between 36 and 39 degrees.
Exclusion criteria would be pregnancy or lactation, under 18 years of age, known allergy to donepezil or medroxyprogesterone, tracheostomy,Any hemodynamic instability, need to be obtained Sedation or unconsciousness, concurrent administration of potentially breathing stimulants such as doxapram and medroxyprogesterone, hypothyroidism
-
Intervention groups
-
One group is the Medroxy Progesterone recipient, the other is Donepezil and the last is the placebo recipient.
-
Main outcome variables
-
Mortality rate, duration of ventilation, length of stay in intensive care unit and hospital, clinicalstatus of patients, hospital discharge, scorpion sofa and GCS.